Project Grant H8G48338

The National Science Foundation (NSF) awarded a $997,689 Cooperative Agreement under its NSF Technology, Innovation, and Partnerships (CFDA 47.084) program to Omnicyte LLC, a minority-owned small business in Branford, CT. The funding supports the design and production of a next-generation COVID-19 vaccine that addresses weaknesses of current vaccines, such as reduced booster effectiveness, short-lived efficacy, and side effects. The project aims to develop a vaccine candidate with improved...

This Project Grant award from the National Institute on Minority Health and Health Disparities (CFDA 93.307 - Minority Health and Health Disparities Research) provides $2,065,719 to New York University to conduct a community-based behavioral intervention study. The goal is to increase COVID-19 and influenza vaccination rates among African American/Black and Latino persons, populations that have experienced disparities in vaccination uptake. The study will test the impact of four intervention...

The Department of Health and Human Services Centers for Disease Control and Prevention (CDC) awarded a $282,526 Cooperative Agreement to the South Carolina Department of Public Health (SCDPH) under the Immunization Cooperative Agreements (CFDA 93.268) program. The award, effective August 1, 2024 through July 31, 2029, will support SCDPH in establishing and maintaining preventive health service programs to immunize individuals against vaccine-preventable diseases such as measles, poliomyelitis,...

This federal Project Grant award of $1,266,296 from the National Institute of Child Health and Human Development (NICHD) under the Child Health and Human Development Extramural Research program (CFDA 93.865) will support research to model the impact of minor vaccine consent (VC) laws on COVID-19 vaccine uptake and transmission among adolescents. The research team at the University of Pittsburgh will develop a comprehensive legal dataset of state and local VC laws, collaborate with community...

This $799,904 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Epidemiology and Laboratory Capacity for Infectious Diseases (CFDA 93.323) program supports the "ARISE COORDINATING AND COLLABORATING CENTERS FOR THE STUDY OF VACCINE HESITANCY AND UPTAKE" project at New York University (NYU) School of Medicine. The project aims to enhance public health infrastructure for detecting, responding to, preventing, and controlling infectious...

The Hawaii Department of Health received a $5,358,220 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the Public Health Emergency Response: Cooperative Agreement for Emergency Response (CFDA 93.354) program. The award will fund the establishment and maintenance of a workgroup within the department to increase vaccination rates in Hawaii, with a focus on populations disproportionately affected by the MPOX outbreak. Key activities will include...

This Project Grant award from the National Institute of Allergy and Infectious Diseases (NIAID), under the Allergy and Infectious Diseases Research program (CFDA 93.855), provides $242,250 to the University of Virginia to develop a vaccine against cryptosporidiosis, a common cause of diarrheal disease in Sub-Saharan Africa and Asia. The key objectives are to optimize the systemic and cellular immune responses to promising vaccine antigens, and to evaluate the protective efficacy of the optimal...

The U.S. Department of Agriculture's National Institute of Food and Agriculture (USDA-NIFA) awarded a $9.5M project grant under the Extension Collaborative on Immunization Teaching & Engagement (EXCITE) program to the Extension Foundation. This grant, spanning from Sep 2024 to May 2027, aims to stabilize and increase routine immunization rates in rural and underserved communities. The key objectives are to: 1) increase public confidence in adult vaccinations through collaboration with...

This $1,980,000 Cooperative Agreement award from the Centers for Disease Control and Prevention (CDC) under the CDC Investigations and Technical Assistance program (CFDA 93.283) will support Jhpiego Corporation in strengthening immunization program implementation in the Philippines. The 5-year award, commencing on September 30, 2024, will focus on improving the delivery of immunization and other essential health services in subnational regions of the Philippines. Jhpiego, a non-profit global...

The U.S. Centers for Disease Control and Prevention (CDC) awarded a $343,302 Cooperative Agreement to the Connecticut Department of Public Health (DPH) under the Immunization Research, Demonstration, Public Information and Education Training and Clinical Skills Improvement Projects program (CFDA 93.185). The funding supports critical core capacity for DPH programs and the State Public Health Laboratory (SPHL) to enhance state and local health capacity in responding to new infectious disease...